SR-96777A

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSR-96777A
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 agonists
TargetsMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi-Synthelabo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Synthelabo
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A